Published in JACC Cardiovasc Imaging on March 01, 2011
Myocardial edema as detected by pre-contrast T1 and T2 CMR delineates area at risk associated with acute myocardial infarction. JACC Cardiovasc Imaging (2012) 2.86
Advances in parametric mapping with CMR imaging. JACC Cardiovasc Imaging (2013) 2.02
Improved detection of myocardial involvement in acute inflammatory cardiomyopathies using T2 mapping. Circ Cardiovasc Imaging (2011) 1.75
Relationship of T2-Weighted MRI Myocardial Hyperintensity and the Ischemic Area-At-Risk. Circ Res (2015) 1.71
Pathophysiology of LV Remodeling in Survivors of STEMI: Inflammation, Remote Myocardium, and Prognosis. JACC Cardiovasc Imaging (2015) 1.69
Prognostic significance of infarct core pathology revealed by quantitative non-contrast in comparison with contrast cardiac magnetic resonance imaging in reperfused ST-elevation myocardial infarction survivors. Eur Heart J (2015) 1.62
Myocardial Hemorrhage After Acute Reperfused ST-Segment-Elevation Myocardial Infarction: Relation to Microvascular Obstruction and Prognostic Significance. Circ Cardiovasc Imaging (2016) 1.60
Distinction of salvaged and infarcted myocardium within the ischaemic area-at-risk with T2 mapping. Eur Heart J Cardiovasc Imaging (2014) 1.57
Myocardial T1 and T2 mapping at 3 T: reference values, influencing factors and implications. J Cardiovasc Magn Reson (2013) 1.40
T2-weighted imaging to assess post-infarct myocardium at risk. JACC Cardiovasc Imaging (2011) 1.40
CMR of microvascular obstruction and hemorrhage in myocardial infarction. J Cardiovasc Magn Reson (2012) 1.33
Variability and homogeneity of cardiovascular magnetic resonance myocardial T2-mapping in volunteers compared to patients with edema. J Cardiovasc Magn Reson (2013) 1.21
Diagnostic and prognostic value of cardiovascular magnetic resonance in non-ischaemic cardiomyopathies. J Cardiovasc Magn Reson (2012) 1.17
Cardiovascular magnetic resonance of myocardial edema using a short inversion time inversion recovery (STIR) black-blood technique: diagnostic accuracy of visual and semi-quantitative assessment. J Cardiovasc Magn Reson (2012) 1.05
Myocardial T₂ mapping with respiratory navigator and automatic nonrigid motion correction. Magn Reson Med (2012) 1.03
Quantification of infarct size and myocardium at risk: evaluation of different techniques and its implications. Eur Heart J Cardiovasc Imaging (2015) 0.99
T1 mapping and T2 mapping at 3T for quantifying the area-at-risk in reperfused STEMI patients. J Cardiovasc Magn Reson (2015) 0.95
Myocardial tissue characterization by magnetic resonance imaging: novel applications of T1 and T2 mapping. J Thorac Imaging (2014) 0.94
Reproducibility of area at risk assessment in acute myocardial infarction by T1- and T2-mapping sequences in cardiac magnetic resonance imaging in comparison to Tc99m-sestamibi SPECT. Int J Cardiovasc Imaging (2014) 0.93
Free-breathing, motion-corrected late gadolinium enhancement is robust and extends risk stratification to vulnerable patients. Circ Cardiovasc Imaging (2013) 0.93
Improved quantitative myocardial T2 mapping: Impact of the fitting model. Magn Reson Med (2014) 0.91
Temporal Evolution of Myocardial Hemorrhage and Edema in Patients After Acute ST-Segment Elevation Myocardial Infarction: Pathophysiological Insights and Clinical Implications. J Am Heart Assoc (2016) 0.90
Myocardial area at risk and salvage measured by T2-weighted cardiovascular magnetic resonance: reproducibility and comparison of two T2-weighted protocols. J Cardiovasc Magn Reson (2011) 0.89
Free-breathing, motion-corrected, highly efficient whole heart T2 mapping at 3T with hybrid radial-cartesian trajectory. Magn Reson Med (2015) 0.89
Brain characterization using normalized quantitative magnetic resonance imaging. PLoS One (2013) 0.88
Calibration of myocardial T2 and T1 against iron concentration. J Cardiovasc Magn Reson (2014) 0.88
Thrombus aspiration during primary percutaneous coronary intervention is associated with reduced myocardial edema, hemorrhage, microvascular obstruction and left ventricular remodeling. J Cardiovasc Magn Reson (2012) 0.88
Quantification of myocardial stiffness using magnetic resonance elastography in right ventricular hypertrophy: initial feasibility in dogs. Magn Reson Imaging (2015) 0.88
Automated Extracellular Volume Fraction Mapping Provides Insights Into the Pathophysiology of Left Ventricular Remodeling Post-Reperfused ST-Elevation Myocardial Infarction. J Am Heart Assoc (2016) 0.87
Cardiovascular magnetic resonance in wet beriberi. J Cardiovasc Magn Reson (2011) 0.86
Gradient Spin Echo (GraSE) imaging for fast myocardial T2 mapping. J Cardiovasc Magn Reson (2015) 0.85
Cardiac MR imaging: current status and future direction. Cardiovasc Diagn Ther (2015) 0.84
Simultaneous three-dimensional myocardial T1 and T2 mapping in one breath hold with 3D-QALAS. J Cardiovasc Magn Reson (2014) 0.84
Myocardial T1 and T2 mapping in diastolic and systolic phase. Int J Cardiovasc Imaging (2015) 0.83
Radiofrequency Ablation, MR Thermometry, and High-Spatial-Resolution MR Parametric Imaging with a Single, Minimally Invasive Device. Radiology (2016) 0.82
Quantitative T2 mapping for detecting myocardial edema after reperfusion of myocardial infarction: validation and comparison with T2-weighted images. Int J Cardiovasc Imaging (2013) 0.82
Fast T2 gradient-spin-echo (T2-GraSE) mapping for myocardial edema quantification: first in vivo validation in a porcine model of ischemia/reperfusion. J Cardiovasc Magn Reson (2015) 0.82
Diagnosis of acute global myocarditis using cardiac MRI with quantitative t1 and t2 mapping: case report and literature review. Korean J Radiol (2013) 0.81
Myocardial edema imaging in acute coronary syndromes. J Magn Reson Imaging (2011) 0.81
The emerging role of cardiovascular magnetic resonance in the evaluation of Kawasaki disease. Int J Cardiovasc Imaging (2013) 0.80
Effect of ischemic postconditioning on myocardial salvage in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the POST randomized trial. Int J Cardiovasc Imaging (2015) 0.80
Parallel simulations for QUAntifying RElaxation magnetic resonance constants (SQUAREMR): an example towards accurate MOLLI T1 measurements. J Cardiovasc Magn Reson (2015) 0.80
Cardiovascular magnetic resonance T2 mapping can detect myocardial edema in idiopathic dilated cardiomyopathy. Int J Cardiovasc Imaging (2014) 0.79
Comparative Prognostic Utility of Indexes of Microvascular Function Alone or in Combination in Patients With an Acute ST-Segment-Elevation Myocardial Infarction. Circulation (2016) 0.79
In vivo, high-frequency three-dimensional cardiac MR elastography: Feasibility in normal volunteers. Magn Reson Med (2016) 0.78
Conditioning the heart to prevent myocardial reperfusion injury during PPCI. Eur Heart J Acute Cardiovasc Care (2012) 0.78
Mapping tissue inhomogeneity in acute myocarditis: a novel analytical approach to quantitative myocardial edema imaging by T2-mapping. J Cardiovasc Magn Reson (2015) 0.78
Comparison of diffusion-weighted with T2-weighted imaging for detection of edema in acute myocardial infarction. J Cardiovasc Magn Reson (2013) 0.78
Nonischemic myocardial changes detected by cardiac magnetic resonance in critical care patients with sepsis. Am J Respir Crit Care Med (2013) 0.78
Role of Imaging Techniques for Diagnosis, Prognosis and Management of Heart Failure Patients: Cardiac Magnetic Resonance. Curr Heart Fail Rep (2015) 0.77
Myocardial area at risk after ST-elevation myocardial infarction measured with the late gadolinium enhancement after scar remodeling and T2-weighted cardiac magnetic resonance imaging. Int J Cardiovasc Imaging (2011) 0.77
Diagnostic Performance of T1 and T2 Mapping to Detect Intramyocardial Hemorrhage in Reperfused ST-Segment Elevation Myocardial Infarction (STEMI) Patients. J Magn Reson Imaging (2017) 0.77
Microvascular resistance of the culprit coronary artery in acute ST-elevation myocardial infarction. JCI Insight (2016) 0.76
Fast in vivo quantification of T1 and T2 MRI relaxation times in the myocardium based on inversion recovery SSFP with in vitro validation post Gd-based contrast administration. Cardiovasc Diagn Ther (2014) 0.76
Advances in molecular imaging of atherosclerosis and myocardial infarction: shedding new light on in vivo cardiovascular biology. Am J Physiol Heart Circ Physiol (2012) 0.76
Joint myocardial T1 and T2 mapping using a combination of saturation recovery and T2 -preparation. Magn Reson Med (2015) 0.76
Mineralocorticoid receptor antagonist pretreatment to MINIMISE reperfusion injury after ST-elevation myocardial infarction (the MINIMISE STEMI Trial): rationale and study design. Clin Cardiol (2015) 0.75
Gadolinium free cardiovascular magnetic resonance with 2-point Cine balanced steady state free precession. J Cardiovasc Magn Reson (2015) 0.75
Myocardial edema in acute ischemic injury. JACC Cardiovasc Imaging (2011) 0.75
Cardiac magnetic resonance imaging for the investigation of cardiovascular disorders. Part 2: emerging applications. Tex Heart Inst J (2014) 0.75
Abnormal T2 mapping cardiovascular magnetic resonance correlates with adverse clinical outcome in patients with suspected acute myocarditis. J Cardiovasc Magn Reson (2017) 0.75
Myocardial Infarct Size by CMR in Clinical Cardioprotection Studies: Insights From Randomized Controlled Trials. JACC Cardiovasc Imaging (2017) 0.75
[The penumbra of the heart in MRI]. Radiologe (2013) 0.75
Non-ST-segment elevation acute coronary syndromes: targeted imaging to refine upstream risk stratification. Circ Cardiovasc Imaging (2012) 0.75
Cardiovascular magnetic resonance tagging imaging correlates with myocardial dysfunction and T2 mapping in idiopathic dilated cardiomyopathy. Int J Cardiovasc Imaging (2014) 0.75
Introduction to Cardiovascular Magnetic Resonance: Technical Principles and Clinical Applications. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2016) 0.75
Role of T1 Mapping in Inherited Cardiomyopathies. Eur Cardiol (2016) 0.75
Myocardial T1 and T2 Mapping: Techniques and Clinical Applications. Korean J Radiol (2017) 0.75
Cardiovascular magnetic resonance imaging assessment of outcomes in acute myocardial infarction. World J Cardiol (2017) 0.75
Current T1 and T2 mapping techniques applied with simple thresholds cannot discriminate acute from chronic myocadial infarction on an individual patient basis: a pilot study. BMC Med Imaging (2016) 0.75
Contemporary cardiovascular imaging methods for the assessment of at-risk myocardium. J Am Heart Assoc (2013) 0.75
Noninvasive Imaging to Evaluate Women With Stable Ischemic Heart Disease. JACC Cardiovasc Imaging (2016) 0.75
Temperature-corrected post-mortem 1.5 T MRI quantification of non-pathologic upper abdominal organs. Int J Legal Med (2017) 0.75
Ferumoxytol-enhanced magnetic resonance imaging assessing inflammation after myocardial infarction. Heart (2017) 0.75
Diagnostic Accuracy of 3.0-T Magnetic Resonance T1 and T2 Mapping and T2-Weighted Dark-Blood Imaging for the Infarct-Related Coronary Artery in Non-ST-Segment Elevation Myocardial Infarction. J Am Heart Assoc (2017) 0.75
Quantitative assessment of salvaged myocardial zone and intramyocardial hemorrhage using non-contrast faster T2 mapping in a rat model by 7T MRI. Exp Ther Med (2017) 0.75
Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson (2017) 0.75
The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med (2000) 13.25
Universal definition of myocardial infarction. Circulation (2007) 11.69
Cardiac magnetic resonance with edema imaging identifies myocardium at risk and predicts worse outcome in patients with non-ST-segment elevation acute coronary syndrome. J Am Coll Cardiol (2010) 5.70
T2 quantification for improved detection of myocardial edema. J Cardiovasc Magn Reson (2009) 3.90
Comparison of magnetic resonance feature tracking for strain calculation with harmonic phase imaging analysis. JACC Cardiovasc Imaging (2010) 3.50
"Black blood" T2-weighted inversion-recovery MR imaging of the heart. Radiology (1996) 3.34
The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. J Am Coll Cardiol (2008) 3.09
Edema as a very early marker for acute myocardial ischemia: a cardiovascular magnetic resonance study. J Am Coll Cardiol (2009) 2.90
Cardiac magnetic resonance with T2-weighted imaging improves detection of patients with acute coronary syndrome in the emergency department. Circulation (2008) 2.74
T2-weighted cardiovascular magnetic resonance imaging. J Magn Reson Imaging (2007) 2.01
Rapid detection of myocardial infarction by subsecond, free-breathing delayed contrast-enhancement cardiovascular magnetic resonance. Circulation (2007) 1.64
Myocardial salvage: retrospection, resolution, and radio waves. Circulation (2006) 1.64
Myocardial edema--a new clinical entity? Nat Rev Cardiol (2010) 1.59
Intramyocardial hemorrhage and microvascular obstruction after primary percutaneous coronary intervention. Int J Cardiovasc Imaging (2009) 1.47
Assessment of postreperfusion myocardial hemorrhage using proton NMR imaging at 1.5 T. Circulation (1992) 1.33
Relationship between progressive microvascular damage and intramyocardial hemorrhage in patients with reperfused anterior myocardial infarction: myocardial contrast echocardiographic study. Circulation (1997) 1.32
Using magnetic resonance imaging to characterize recent myocardial injury: utility in acute coronary syndrome and other clinical scenarios. Circulation (2008) 1.21
Hemorrhagic myocardial infarction after coronary reperfusion detected in vivo by magnetic resonance imaging in humans: prevalence and clinical implications. J Cardiovasc Magn Reson (1999) 1.08
The effect of postinfarction intramyocardial hemorrhage on transverse relaxation time. Magn Reson Med (1992) 1.06
Demonstration of the "no-reflow" phenomenon in the dog heart after temporary ischemia. Recent Adv Stud Cardiac Struct Metab (1975) 0.96
Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation (2010) 19.30
In-center hemodialysis six times per week versus three times per week. N Engl J Med (2010) 10.73
Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography. JAMA (2007) 8.88
Beyond medications and diet: alternative approaches to lowering blood pressure: a scientific statement from the american heart association. Hypertension (2013) 5.88
Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model. JAMA (2005) 5.83
Cardiac magnetic resonance with edema imaging identifies myocardium at risk and predicts worse outcome in patients with non-ST-segment elevation acute coronary syndrome. J Am Coll Cardiol (2010) 5.70
Inhalation of fine particulate air pollution and ozone causes acute arterial vasoconstriction in healthy adults. Circulation (2002) 4.71
Ambient air pollution exaggerates adipose inflammation and insulin resistance in a mouse model of diet-induced obesity. Circulation (2009) 4.71
Does this patient have hearing impairment? JAMA (2006) 4.34
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27
Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial. JAMA (2011) 4.09
T2 quantification for improved detection of myocardial edema. J Cardiovasc Magn Reson (2009) 3.90
Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinations. J Cardiovasc Magn Reson (2009) 3.17
Acute blood pressure responses in healthy adults during controlled air pollution exposures. Environ Health Perspect (2005) 3.14
Self-gated cardiac cine MRI. Magn Reson Med (2004) 2.97
Insights into the mechanisms and mediators of the effects of air pollution exposure on blood pressure and vascular function in healthy humans. Hypertension (2009) 2.88
Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. JACC Cardiovasc Imaging (2009) 2.56
Altered tetrahydrobiopterin metabolism in atherosclerosis: implications for use of oxidized tetrahydrobiopterin analogues and thiol antioxidants. Arterioscler Thromb Vasc Biol (2002) 2.53
Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis. Circulation (2011) 2.52
Radiation dose and cancer risk estimates in 16-slice computed tomography coronary angiography. J Nucl Cardiol (2008) 2.33
Exercise ameliorates high-fat diet-induced metabolic and vascular dysfunction, and increases adipocyte progenitor cell population in brown adipose tissue. Am J Physiol Regul Integr Comp Physiol (2011) 2.23
Myocardial first-pass perfusion cardiovascular magnetic resonance: history, theory, and current state of the art. J Cardiovasc Magn Reson (2008) 2.08
Airborne particulate matter selectively activates endoplasmic reticulum stress response in the lung and liver tissues. Am J Physiol Cell Physiol (2010) 2.06
Early treatment with lisinopril and spironolactone preserves cardiac and skeletal muscle in Duchenne muscular dystrophy mice. Circulation (2011) 2.06
Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the Renal Research Institute-CKD study. Am J Kidney Dis (2005) 2.05
Air pollution exposure potentiates hypertension through reactive oxygen species-mediated activation of Rho/ROCK. Arterioscler Thromb Vasc Biol (2008) 1.97
Effect of early particulate air pollution exposure on obesity in mice: role of p47phox. Arterioscler Thromb Vasc Biol (2010) 1.88
Chronic fine particulate matter exposure induces systemic vascular dysfunction via NADPH oxidase and TLR4 pathways. Circ Res (2011) 1.83
Improved detection of myocardial involvement in acute inflammatory cardiomyopathies using T2 mapping. Circ Cardiovasc Imaging (2011) 1.75
Cardiologist concordance with the American College of Cardiology appropriate use criteria for cardiac testing in patients with coronary artery disease. Am J Cardiol (2012) 1.70
In vivo atherosclerotic plaque characterization using magnetic susceptibility distinguishes symptom-producing plaques. JACC Cardiovasc Imaging (2008) 1.69
Air pollution: the "Heart" of the problem. Curr Hypertens Rep (2003) 1.65
Long-term exposure to ambient fine particulate pollution induces insulin resistance and mitochondrial alteration in adipose tissue. Toxicol Sci (2011) 1.65
Myocardial ischemia in asymptomatic adults with repaired aortic coarctation. Int J Cardiol (2008) 1.62
Visceral adipose inflammation in obesity is associated with critical alterations in tregulatory cell numbers. PLoS One (2011) 1.60
Particulate matter, air pollution, and blood pressure. J Am Soc Hypertens (2010) 1.58
Hypertonic saline attenuates cord swelling and edema in experimental spinal cord injury: a study utilizing magnetic resonance imaging. Crit Care Med (2009) 1.54
Automated rectilinear self-gated cardiac cine imaging. Magn Reson Med (2004) 1.52
Pulmonary arterial hypertension: noninvasive detection with phase-contrast MR imaging. Radiology (2007) 1.52
Ocular pressure waveform reflects ventricular bigeminy and aortic insufficiency. Indian J Ophthalmol (2015) 1.50
Association between markers of collagen turnover, arterial stiffness and left ventricular hypertrophy in chronic kidney disease (CKD): the Renal Research Institute (RRI)-CKD study. Nephrol Dial Transplant (2011) 1.50
Relative contributions of PM2.5 chemical constituents to acute arterial vasoconstriction in humans. Inhal Toxicol (2004) 1.49
Diesel exhaust exposure induces angiogenesis. Toxicol Lett (2009) 1.48
Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations. Circ Cardiovasc Imaging (2011) 1.47
Automated quantification of mitral inflow and aortic outflow stroke volumes by three-dimensional real-time volume color-flow Doppler transthoracic echocardiography: comparison with pulsed-wave Doppler and cardiac magnetic resonance imaging. J Am Soc Echocardiogr (2011) 1.46
Multislice computed tomography in the exclusion of coronary artery disease in patients with presurgical valve disease. Circ Cardiovasc Imaging (2009) 1.46
Preliminary investigation of respiratory self-gating for free-breathing segmented cine MRI. Magn Reson Med (2005) 1.46
Impact of 64-slice multidetector computed tomography on other diagnostic studies for coronary artery disease. Am J Med (2009) 1.44
Air pollution and cardiac remodeling: a role for RhoA/Rho-kinase. Am J Physiol Heart Circ Physiol (2009) 1.44
Sustained vascular endothelial growth factor delivery enhances angiogenesis and perfusion in ischemic hind limb. Pharm Res (2005) 1.43
Inhibitor κB kinase 2 is a myosin light chain kinase in vascular smooth muscle. Circ Res (2013) 1.42
Simultaneous right and left heart real-time, free-breathing CMR flow quantification identifies constrictive physiology. JACC Cardiovasc Imaging (2012) 1.40
Ambient air particulate matter exposure and tissue factor expression in atherosclerosis. Inhal Toxicol (2008) 1.40
Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo. Circ Cardiovasc Imaging (2009) 1.39
Impaired vasoreactivity despite an increase in plasma nitrite in patients with abdominal aortic aneurysms. J Vasc Surg (2002) 1.39
Acute myocardial infarction in early pregnancy: definition of myocardium at risk with noncontrast T2-weighted cardiac magnetic resonance. Am J Obstet Gynecol (2008) 1.39
Pulmonary vascular hemodynamic response to exercise in cardiopulmonary diseases. Circulation (2013) 1.35
Cardiac function: MR evaluation in one breath hold with real-time true fast imaging with steady-state precession. Radiology (2002) 1.34
Magnetic resonance versus radionuclide pharmacological stress perfusion imaging for flow-limiting stenoses of varying severity. Circulation (2004) 1.33
Motion-corrected free-breathing delayed enhancement imaging of myocardial infarction. Magn Reson Med (2005) 1.32
TrueFISP: assessment of accuracy for measurement of left ventricular mass in an animal model. J Magn Reson Imaging (2002) 1.31
Particulate matter air pollution and atherosclerosis. Curr Atheroscler Rep (2010) 1.29
Long-term fine particulate matter exposure and mortality from diabetes in Canada. Diabetes Care (2013) 1.29
Exposure to ambient particulate matter induces a NASH-like phenotype and impairs hepatic glucose metabolism in an animal model. J Hepatol (2012) 1.28
An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: potential implications in cardiovascular disease. Atherosclerosis (2012) 1.27
Myocardial infarction: optimization of inversion times at delayed contrast-enhanced MR imaging. Radiology (2004) 1.27
T-cell costimulation protects obesity-induced adipose inflammation and insulin resistance. Diabetes (2013) 1.27
Effect of hypoxia-inducible factor-1alpha gene therapy on walking performance in patients with intermittent claudication. Circulation (2011) 1.25
A method to assess spatially variant noise in dynamic MR image series. Magn Reson Med (2010) 1.24
Neutral effect on markers of heart failure, inflammation, endothelial activation and function, and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein level. J Am Coll Cardiol (2005) 1.22
Ambient particulate air pollution induces oxidative stress and alterations of mitochondria and gene expression in brown and white adipose tissues. Part Fibre Toxicol (2011) 1.22
Cardiovascular remodeling in response to long-term exposure to fine particulate matter air pollution. Circ Heart Fail (2012) 1.20
Reduced metabolic insulin sensitivity following sub-acute exposures to low levels of ambient fine particulate matter air pollution. Sci Total Environ (2012) 1.19
Predictors of heart rate variability and its prognostic significance in chronic kidney disease. Nephrol Dial Transplant (2011) 1.18
MR Imaging of the heart with cine true fast imaging with steady-state precession: influence of spatial and temporal resolutions on left ventricular functional parameters. Radiology (2002) 1.18
Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function. J Cardiovasc Magn Reson (2013) 1.18
Application of the Karhunen-Loeve transform temporal image filter to reduce noise in real-time cardiac cine MRI. Phys Med Biol (2009) 1.16
Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials. Circ Cardiovasc Imaging (2012) 1.16
Prevalence and correlates of septal delayed contrast enhancement in patients with pulmonary hypertension. Am J Cardiol (2007) 1.15
Common data elements for clinical research in Friedreich's ataxia. Mov Disord (2012) 1.14
Multislice first-pass myocardial perfusion imaging: Comparison of saturation recovery (SR)-TrueFISP-two-dimensional (2D) and SR-TurboFLASH-2D pulse sequences. J Magn Reson Imaging (2004) 1.14
Effects of concentrated fine ambient particles on rat plasma levels of asymmetric dimethylarginine. Inhal Toxicol (2004) 1.14
Cardiac function and myocardial perfusion immediately following maximal treadmill exercise inside the MRI room. J Cardiovasc Magn Reson (2008) 1.14
A potential role for dendritic cell/macrophage-expressing DPP4 in obesity-induced visceral inflammation. Diabetes (2012) 1.13
Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis. Circulation (2003) 1.11
Congenital absence of the left atrial appendage. Circ Cardiovasc Imaging (2012) 1.09
Letter by Mehta Oza and Raman regarding article, "Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot RenPro Trial (Renal Protection Trial)". Circulation (2013) 1.09